Skip to main content
. 2020 Aug 25;12(9):807. doi: 10.3390/pharmaceutics12090807

Figure 5.

Figure 5

Photomicrographs from the liver of the (A): control (untreated), (B): orally treated (TAMX), (C): topically treated with emu oil (without the presence of drugs), formulations; (D): DLT (85:15) and (E): DLT–EO (85:15) at day 18 post treatment. H&E magnification 100× Note: DLT—deformable liposomes, DLT–EO—deformable liposomes with emu oil, CV—central vein.